Publication year |
Human health effect |
Ecological effect |
Detailed assessment by experts |
Remarks |
Exposure Class |
Hazard Class |
Priority |
Exposure Class |
Hazard Class |
Priority |
2023 |
- |
- |
- |
5 |
4 |
Low |
|
Assessment has been conducted by the serial number of Priority Assessment Chemical Substances (PACSs). |
2022 |
- |
- |
- |
5 |
4 |
Low |
|
Assessment has been conducted by the serial number of Priority Assessment Chemical Substances (PACSs). |
2021 |
- |
- |
- |
5 |
4 |
Low |
|
Assessment has been conducted by the serial number of Priority Assessment Chemical Substances (PACSs). |
2020 |
|
|
|
5 |
4 |
Low |
|
Assessment has been conducted by the serial number of Priority Assessment Chemical Substances (PACSs). |
2019 |
|
|
|
5 |
4 |
Low |
|
Assessment has been conducted by the serial number of Priority Assessment Chemical Substances (PACSs). |
2018 |
|
|
|
5 |
4 |
Low |
|
Assessment has been conducted by the serial number of Priority Assessment Chemical Substances (PACSs). |
2017 |
|
|
|
5 |
4 |
Low |
|
Assessment has been conducted by the serial number of Priority Assessment Chemical Substances (PACSs). |
2016 |
|
|
|
5 |
4 |
Low |
|
Assessment has been conducted by the serial number of Priority Assessment Chemical Substances (PACSs). |
2015 |
|
|
|
5 |
4 |
Low |
|
Assessment has been conducted by the serial number of Priority Assessment Chemical Substances (PACSs). |
2012 |
2 |
3 |
High |
4 |
- |
- |
|
Assessment has been conducted by the CAS RN. |
publication date |
Status of risk assessment |
publication source |
Remarks |
2024/04/01 |
Risk Assessment Phase 1-I (human health effect) |
|
|
2023/04/01 |
Risk Assessment Phase 1-I (human health effect) |
|
|
2022/04/01 |
Risk Assessment Phase 1-I (human health effect) |
|
|
2021/04/01 |
Risk Assessment Phase 1-I (human health effect) |
|
|
2020/04/01 |
Risk Assessment Phase 1-I (human health effect) |
|
|
2019/04/01 |
Risk Assessment Phase 1-I (human health effect) |
|
|
2018/03/22 |
Risk Assessment Phase 1-I (human health effect) |
|
|
2016/12/27 |
Risk Assessment Phase 1-I (human health effect) |
|
|
2015/11/26 |
Risk Assessment Phase 1-I |
|
|
2014/07/31 |
Risk Assessment Phase 1-I |
|
|
Fiscal year |
MITI Number |
Registration No. |
Chemical Substance Name |
Classification |
Manufactured and/or imported quantities (t) |
Remarks |
2022 |
5-113 |
136 |
N-Methyl-2-pyrrolidone |
Priority Assessment Chemical Substances (PACSs) |
26,125 |
|
2021 |
5-113 |
136 |
N-Methyl-2-pyrrolidone |
Priority Assessment Chemical Substances (PACSs) |
28,341 |
|
2020 |
5-113 |
136 |
N-Methyl-2-pyrrolidone |
Priority Assessment Chemical Substances (PACSs) |
22,243 |
|
2019 |
5-113 |
136 |
N-Methyl-2-pyrrolidone |
Priority Assessment Chemical Substances (PACSs) |
22,560 |
|
2018 |
5-113 |
136 |
N-Methyl-2-pyrrolidone |
Priority Assessment Chemical Substances (PACSs) |
23,355 |
|
2017 |
5-113 |
136 |
N-Methyl-2-pyrrolidone |
Priority Assessment Chemical Substances (PACSs) |
20,934 |
|
2016 |
5-113 |
136 |
N-Methyl-2-pyrrolidone |
Priority Assessment Chemical Substances (PACSs) |
19,138 |
|
2015 |
5-113 |
136 |
N-Methyl-2-pyrrolidone |
Priority Assessment Chemical Substances (PACSs) |
18,494 |
|
2014 |
5-113 |
136 |
N-Methyl-2-pyrrolidone |
Priority Assessment Chemical Substances (PACSs) |
17,245 |
|
2013 |
5-113 |
136 |
N-Methyl-2-pyrrolidone |
Priority Assessment Chemical Substances (PACSs) |
15,791 |
|
2012 |
5-113 |
136 |
N-Methyl-2-pyrrolidone |
Priority Assessment Chemical Substances (PACSs) |
13,554 |
|
NITE-CHRIP
Link to "Search Results of NITE-CHRIP".
-When the substace dosen't have CAS RN, it shows the J-CHECK page.
-When there is no data on NITE-CHRIP, it shows the NITE-CHRIP error page.

Search by CAS RN in eChemPortal.
J-CHECK has participated in eChemPortal.
eChemPortal